NO172855C - Fremgangsmaate for fremstilling av et herpes simplex virusgd glycoprotein - Google Patents

Fremgangsmaate for fremstilling av et herpes simplex virusgd glycoprotein

Info

Publication number
NO172855C
NO172855C NO832626A NO832626A NO172855C NO 172855 C NO172855 C NO 172855C NO 832626 A NO832626 A NO 832626A NO 832626 A NO832626 A NO 832626A NO 172855 C NO172855 C NO 172855C
Authority
NO
Norway
Prior art keywords
virusgd
glycoprotein
procedure
preparation
herpes simplex
Prior art date
Application number
NO832626A
Other languages
English (en)
Other versions
NO172855B (no
NO832626L (no
Inventor
Roger John Watson
John Haynes Weis
Lynn William Enquist
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27410368&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO172855(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/400,028 external-priority patent/US4818694A/en
Priority claimed from US06/510,551 external-priority patent/US4891315A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO832626L publication Critical patent/NO832626L/no
Publication of NO172855B publication Critical patent/NO172855B/no
Publication of NO172855C publication Critical patent/NO172855C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO832626A 1982-07-20 1983-07-19 Fremgangsmaate for fremstilling av et herpes simplex virusgd glycoprotein NO172855C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/400,028 US4818694A (en) 1982-07-20 1982-07-20 Production of herpes simplex viral protein
US43636882A 1982-10-25 1982-10-25
US06/510,551 US4891315A (en) 1982-10-25 1983-07-06 Production of herpes simplex viral porteins

Publications (3)

Publication Number Publication Date
NO832626L NO832626L (no) 1984-01-23
NO172855B NO172855B (no) 1993-06-07
NO172855C true NO172855C (no) 1993-09-15

Family

ID=27410368

Family Applications (1)

Application Number Title Priority Date Filing Date
NO832626A NO172855C (no) 1982-07-20 1983-07-19 Fremgangsmaate for fremstilling av et herpes simplex virusgd glycoprotein

Country Status (14)

Country Link
EP (1) EP0101655B1 (no)
CA (1) CA1295561C (no)
DE (1) DE3382072D1 (no)
DK (1) DK333183A (no)
ES (2) ES524245A0 (no)
FI (1) FI83974C (no)
GR (1) GR78647B (no)
IE (1) IE56902B1 (no)
IL (1) IL69269A (no)
NO (1) NO172855C (no)
NZ (1) NZ204948A (no)
PH (1) PH21239A (no)
PL (1) PL150654B1 (no)
PT (1) PT77014B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3228501A1 (de) * 1982-07-30 1984-02-02 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines herpes-antigens, dazu geeignetes mittel sowie verfahren zu seiner herstellung und die verwendung dieses antigens
DE3461928D1 (en) * 1983-06-23 1987-02-12 Person Stanley Immunologically reactive non-glycosylated amino acid chains of glycoprotein b of herpes virus types 1 and 2
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
US7264817B1 (en) 1983-08-30 2007-09-04 Genentech, Inc. Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it
NZ209307A (en) * 1983-08-30 1990-07-26 Genentech Inc Diagnostic product: antigenic peptide produced by recombinant dna techniques
JPS615786A (ja) * 1984-06-19 1986-01-11 Chemo Sero Therapeut Res Inst 単純ヘルペスウイルス遺伝子を組込んだ組換えｄｎａ、形質転換動物細胞および単純ヘルペスウイルス蛋白質の製法
DE3582200D1 (de) * 1984-07-20 1991-04-25 Chemo Sero Therapeut Res Inst Rekombinante dns, enthaltend ein herpes-simplex-virus-gen oder ein fragment davon, hefe transformiert mit dieser rekombinanten dns und verfahren zur herstellung von herpes-simplex-virus-proteinen.
US4659568A (en) * 1985-02-27 1987-04-21 American Cyanamid Company Process for solubilization, purification and characterization of protein from insoluble protein aggregates or complexes and compositions of matter therefrom
DE3510734A1 (de) * 1985-03-25 1986-09-25 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines fuer herpes simplex virus typ 2 spezifischen antigens, dazu geeignetes mittel und verwendung dieses antigens
JPH0668B2 (ja) * 1985-08-30 1994-01-05 財団法人化学及血清療法研究所 単純ヘルペスウイルス遺伝子が組込まれた組換えプラスミド
WO1990013652A1 (en) * 1989-05-12 1990-11-15 Triton Diagnostics, Inc. Herpes simplex virus type 2-glycoprotein g proteins and polypeptides
US5149532A (en) * 1989-11-01 1992-09-22 Cedars Sinai Medical Center Method of vaccine or toxoid preparation and immunization by colonization with recombinant microorganisms
US8541002B2 (en) 2003-09-12 2013-09-24 Agenus Inc. Vaccine for treatment and prevention of herpes simplex virus infection
US10918712B2 (en) 2014-03-03 2021-02-16 Albert Einstein College Of Medicine Passive transfer of immunity using recombinant herpes simplex virus 2 (HSV-2) vaccine vectors
CA2942166A1 (en) * 2014-03-03 2015-09-11 Albert Einstein College Of Medicine, Inc. Recombinant herpes simplex virus 2 (hsv-2) vaccine vectors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3228501A1 (de) * 1982-07-30 1984-02-02 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines herpes-antigens, dazu geeignetes mittel sowie verfahren zu seiner herstellung und die verwendung dieses antigens

Also Published As

Publication number Publication date
PT77014A (en) 1983-08-01
IL69269A (en) 1989-12-15
FI832632A (fi) 1984-01-21
ES8505253A1 (es) 1985-05-16
NZ204948A (en) 1987-10-30
NO172855B (no) 1993-06-07
DE3382072D1 (de) 1991-02-07
IE831690L (en) 1984-01-20
CA1295561C (en) 1992-02-11
FI83974C (fi) 1991-09-25
ES529225A0 (es) 1985-05-16
DK333183A (da) 1984-01-21
FI832632A0 (fi) 1983-07-19
PL150654B1 (en) 1990-06-30
EP0101655A3 (en) 1985-12-18
PT77014B (en) 1986-01-24
GR78647B (no) 1984-09-27
ES8504254A1 (es) 1985-04-01
EP0101655B1 (en) 1991-01-02
DK333183D0 (da) 1983-07-19
FI83974B (fi) 1991-06-14
IE56902B1 (en) 1992-01-29
EP0101655A2 (en) 1984-02-29
PH21239A (en) 1987-08-21
NO832626L (no) 1984-01-23
ES524245A0 (es) 1985-04-01
IL69269A0 (en) 1983-11-30
PL243134A1 (en) 1984-08-13

Similar Documents

Publication Publication Date Title
ES503528A0 (es) Un procedimiento para la preparacion de interferon
ES554935A0 (es) Un procedimiento para la preparacion de pirazolo- y piridazo-pirazolinas, -piridazinas y -diacepinas
ES526295A0 (es) Un procedimiento para la preparacion de derivados de 1-normon-2-ilo
ES506141A0 (es) Un procedimiento para la preparacion de piridin- y pira- cin-derivados
NO832626L (no) Fremgangsmaate for fremstilling av et herpes simplex virusgd glycoprotein
ES524399A0 (es) Un procedimiento para la preparacion de derivados de milbenicina d
GB8521305D0 (en) Optical projectors
DE3364029D1 (en) Combustor
ES544250A0 (es) Un procedimiento para la preparacion de benzoquinolicinas
ES528491A0 (es) Un procedimiento para la preparacion de nuevos derivados de penem 2-tiosustituidos
ES540343A0 (es) Un procedimiento para la preparacion de derivados de piperi-dina
ES524815A0 (es) Procedimiento para la preparacion de un (tio)-eter de 2-metil-liserg-8-ilo
ES527804A0 (es) Un procedimiento para la preparacion de derivados de oxacefalosporina
ES550012A0 (es) Un procedimiento para la preparacion del plasmido pcz101
ES501232A0 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
ES526400A0 (es) Un procedimiento para la preparacion de pirrolopirroles
ES526293A0 (es) Un procedimiento para la preparacion de derivados pentaciclicos
ES501277A0 (es) Un procedimiento para la preparacion de perfluoroamidas
ES537782A0 (es) Un procedimiento para la preparacion de 2-cloro-3-trifluorme-tilbenzaldehido
ES525961A0 (es) Un procedimiento para la preparacion de a53868 factor a
ES535853A0 (es) Un procedimiento para la preparacion de carboxialquil-dipeptidos
ES528700A0 (es) Un procedimiento de preparacion de derivados de pirimidina
ES527584A0 (es) Un procedimiento de preparacion de derivados bencilidenicos
ES534006A0 (es) Un procedimiento de preparacion de hexahidro-indolo-naftiridinas
ES544878A0 (es) Un procedimiento para la preparacion de n-metil-11-aza-10- desoxo-10-dihidroeritromicina a

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN JULY 2003